S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
3 Great Healthcare Stocks to Buy Now
Telecommunications Sector: 3 Must-See Stocks for 2022
Bitcoin pyramid schemes wreak havoc on Brazil's 'New Egypt'
Telecommunications Sector: 3 Must-See Stocks for 2022
Regaining Control of Your Sleep Life...From a (Recovering) Insomniac Entrepreneur
High fertilizer prices could mean smaller crops for farmers
Mexico's energy reform strains ties with US
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
3 Great Healthcare Stocks to Buy Now
Telecommunications Sector: 3 Must-See Stocks for 2022
Bitcoin pyramid schemes wreak havoc on Brazil's 'New Egypt'
Telecommunications Sector: 3 Must-See Stocks for 2022
Regaining Control of Your Sleep Life...From a (Recovering) Insomniac Entrepreneur
High fertilizer prices could mean smaller crops for farmers
Mexico's energy reform strains ties with US
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
3 Great Healthcare Stocks to Buy Now
Telecommunications Sector: 3 Must-See Stocks for 2022
Bitcoin pyramid schemes wreak havoc on Brazil's 'New Egypt'
Telecommunications Sector: 3 Must-See Stocks for 2022
Regaining Control of Your Sleep Life...From a (Recovering) Insomniac Entrepreneur
High fertilizer prices could mean smaller crops for farmers
Mexico's energy reform strains ties with US
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
3 Great Healthcare Stocks to Buy Now
Telecommunications Sector: 3 Must-See Stocks for 2022
Bitcoin pyramid schemes wreak havoc on Brazil's 'New Egypt'
Telecommunications Sector: 3 Must-See Stocks for 2022
Regaining Control of Your Sleep Life...From a (Recovering) Insomniac Entrepreneur
High fertilizer prices could mean smaller crops for farmers
Mexico's energy reform strains ties with US
NASDAQ:NVCR

NovoCure Earnings Date, Estimates, & History

$67.18
-2.92 (-4.17%)
(As of 01/21/2022 04:00 PM ET)
Add
Compare
Today's Range
$65.92
▼
$71.32
50-Day Range
$64.18
▼
$113.32
52-Week Range
$60.57
▼
$232.76
Volume
752,830 shs
Average Volume
946,423 shs
Market Capitalization
$6.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.89

Earnings Summary

Upcoming
Earnings Date
Feb. 24
Confirmed

Actual EPS
(Oct. 28)
-$0.13
Missed By -$0.07

Consensus EPS
(Oct. 28)
-$0.06

Last Year's Q4 EPS
(10/29/2020)
$0.09

Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NovoCure Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NovoCure Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NovoCure (NASDAQ:NVCR) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20223($0.10)($0.05)($0.07) 
Q2 20223($0.13)($0.04)($0.08) 
Q3 20223($0.15)($0.02)($0.06) 
Q4 20223($0.17)$0.00($0.08) 
FY 202212($0.55)($0.11)($0.30)
Q1 20231$0.00$0.00$0.00 
Q2 20231$0.01$0.01$0.01 
Q3 20231$0.03$0.03$0.03 
Q4 20231$0.05$0.05$0.05 
FY 20234$0.09$0.09$0.09

NVCR Earnings Information

NovoCure last announced its quarterly earnings data on October 28th, 2021. The medical equipment provider reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.06) by $0.07. The business earned $133.61 million during the quarter, compared to analysts' expectations of $141.22 million. Its quarterly revenue was up .7% compared to the same quarter last year. NovoCure has generated ($0.27) earnings per share over the last year (($0.27) diluted earnings per share). Earnings for NovoCure are expected to grow in the coming year, from ($0.41) to ($0.23) per share. NovoCure has confirmed that its next quarterly earnings report will be published on Thursday, February 24th, 2022. NovoCure will be holding an earnings conference call on Thursday, February 24th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

NovoCure (NASDAQ:NVCR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/24/2022
(Confirmed)		 ($0.10)       
10/28/20219/30/2021($0.06)($0.13)($0.07)($0.13)$141.22 million$133.61 million    
7/29/20216/30/2021$0.02($0.14)($0.16)($0.14)$141.50 million$133.52 million      
4/29/20213/31/2021$0.02($0.04)($0.06)($0.04)$136.54 million$134.70 million    
2/25/202112/31/2020$0.13$0.04($0.09)$0.04$143.49 million$144.00 million    
10/29/20209/30/2020$0.04$0.09+$0.05$0.09$120.02 million$132.70 million    
7/30/20206/30/2020$0.01$0.02+$0.01$0.02$105.96 million$115.90 million    
4/30/20203/31/2020$0.03$0.04+$0.01$0.04$102.10 million$101.83 million    
2/27/202012/31/2019$0.02$0.04+$0.02$0.04$99.10 million$99.23 million    
10/31/2019Q3($0.05)$0.02+$0.07$0.02$87.12 million$92.06 million  
7/25/2019Q2($0.07)($0.01)+$0.06($0.01)$78.98 million$86.70 million  
5/2/20193/31/2019($0.13)($0.13)($0.13)$72.85 million$73.31 million
2/28/2019Q4 2018($0.15)($0.17)($0.02)($0.17)$69.67 million
10/25/20189/30/2018($0.15)($0.13)+$0.02($0.13)$65.61 million$64.76 million
7/26/2018Q2($0.16)($0.17)($0.01)($0.17)$59.53 million$61.50 million
4/26/20183/31/2018($0.13)($0.23)($0.10)($0.23)$57.13 million$52.13 million
2/22/2018Before Market($0.14)($0.12)+$0.02($0.12)$53.17 million$53.66 million  
10/26/20179/30/2017($0.20)($0.13)+$0.07($0.13)$43.45 million$50.10 million
7/27/20176/30/2017($0.23)($0.24)($0.01)($0.24)$42.20 million$38.38 million
4/27/20173/31/2017($0.25)($0.21)+$0.04($0.21)$39.46 million$34.88 million
2/23/2017Q416($0.39)($0.26)+$0.13($0.26)$26.95 million$30.20 million
11/2/2016Q3 2016($0.42)($0.39)+$0.03($0.39)$21.65 million$21.67 million
7/28/2016Q216($0.37)($0.48)($0.11)($0.48)$15.90 million$17.90 million  
5/9/2016Q116($0.33)($0.42)($0.09)($0.42)$23.65 million$13.10 million
2/29/2016Q4 2015($0.32)$2.54+$2.86$2.54$17.85 million$12.38 million
10/26/2015Q315($2.09)($2.09)($2.09)$4.37 million$8.95 million
(Earnings results data provided by Zacks Investment Research)












NovoCure (NASDAQ:NVCR) Earnings Frequently Asked Questions

When is NovoCure's earnings date?

NovoCure has confirmed that its next quarterly earnings data will be published on Thursday, February 24th, 2022. Learn more on NVCR's earnings history

Did NovoCure beat their earnings estimates last quarter?

In the previous quarter, NovoCure (NASDAQ:NVCR) missed the analysts' consensus estimate of ($0.06) by $0.07 with a reported earnings per share (EPS) of ($0.13). Learn more on NVCR's earnings details

How can I listen to NovoCure's earnings conference call?

The conference call for NovoCure's latest earnings report can be listened to online. Listen to Conference Call

How can I read NovoCure's conference call transcript?

The conference call transcript for NovoCure's latest earnings report can be read online. Read Transcript

How much revenue does NovoCure generate each year?

NovoCure (NASDAQ:NVCR) has a recorded annual revenue of $494.37 million.

How much profit does NovoCure generate each year?

NovoCure (NASDAQ:NVCR) has a recorded net income of $19.81 million. NVCR has generated -$0.27 earnings per share over the last four quarters.

What is NovoCure's EPS forecast for next year?

NovoCure's earnings are expected to grow from ($0.41) per share to ($0.23) per share in the next year.

This page was last updated on 1/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.